Classification of Alzheimer's Disease and Parkinson's Disease by Using Machine Learning and Neural Network Methods

Data mining is a fast evolving technology, is being adopted in biomedical sciences and research. Data mining in medicine is an emerging field of high importance for providing prognosis and a deeper understanding of the classification of neurodegenerative diseases. Given a data set of consists of 487 patients records collected from ADRC, USA. Around eight hundred and ninety patients were recruited to ADRC and diagnosed for AD (65%) and PD (40%), according to the established criteria. In our study we concentrated particularly on the major risk factors which are responsible for Alzheimer’s disease and Parkinson’s disease. This paper proposes a new model for the classification of Alzheimer’s disease and Parkinson’s disease by considering the most influencing risk factors. The main focus was on the selection of most influencing risk factors for both AD and PD using various attribute evaluation scheme with ranker search method. Different models for the classification of AD and PD using various classification techniques such as Neural Networks (NN) and Machine Learning (ML) methods were also developed. It was found that some specific genetic factors, diabetes, age and smoking were the strongest risk factors for Alzheimer’s disease. Similarly, for the classification of Parkinson’s disease, the risk factors such as stroke, diabetes, genes and age were the vital factors.

[1]  B. Lernfelt,et al.  15-year longitudinal study of blood pressure and dementia , 1996, The Lancet.

[2]  D. Capuzzi,et al.  Hypercholesterolemia. The NCEP Adult Treatment Panel III Guidelines. , 2003, Geriatrics.

[3]  H Jick,et al.  Statins and the risk of dementia , 2000, The Lancet.

[4]  A Hofman,et al.  Atrial fibrillation and dementia in a population-based study. The Rotterdam Study. , 1997, Stroke.

[5]  R. Mayeux,et al.  Diabetes mellitus and risk of Alzheimer's disease and dementia with stroke in a multiethnic cohort. , 2001, American journal of epidemiology.

[6]  M. Folstein,et al.  Clinical diagnosis of Alzheimer's disease , 1984, Neurology.

[7]  Sudha Seshadri,et al.  Residual lifetime risk for developing hypertension in middle-aged women and men: The Framingham Heart Study. , 2002, JAMA.

[8]  Leo Breiman,et al.  Random Forests , 2001, Machine Learning.

[9]  Carsten Maple,et al.  Creating a Forest of Binary Search Trees for a Multiprocessor System , 2006, International Symposium on Parallel Computing in Electrical Engineering (PARELEC'06).

[10]  A. Ott Risk of dementia: The Rotterdam Study , 1997 .

[11]  Frank L. Lewis,et al.  Robust backstepping control of nonlinear systems using neural networks , 2000, IEEE Trans. Syst. Man Cybern. Part A.

[12]  Martin D. Buhmann,et al.  Radial Basis Functions: Theory and Implementations: Preface , 2003 .

[13]  A. Hofman,et al.  Smoking and risk of dementia and Alzheimer's disease in a population-based cohort study: the Rotterdam Study , 1998, The Lancet.

[14]  R. Mayeux,et al.  The influence of smoking on the risk of Alzheimer’s disease , 1999, Neurology.

[15]  L. Launer,et al.  Type 2 diabetes, APOE gene, and the risk for dementia and related pathologies: The Honolulu-Asia Aging Study. , 2002, Diabetes.

[16]  Ust Beijing,et al.  Data Mining and Knowledge Discovery in Databases , 1999 .

[17]  E. Kokmen,et al.  The risk of dementia among persons with diabetes mellitus: a population-based cohort study. , 1997 .

[18]  Sudha Seshadri,et al.  Plasma Homocysteine as a Risk Factor for Dementia and Alzheimer's Disease , 2002 .

[19]  K. Flegal,et al.  Prevalence of Diabetes, Impaired Fasting Glucose, and Impaired Glucose Tolerance in U.S. Adults: The Third National Health and Nutrition Examination Survey, 1988–1994 , 1998, Diabetes Care.

[20]  H. Braak,et al.  Neuropathological stageing of Alzheimer-related changes , 2004, Acta Neuropathologica.